ProTrading24ru

Moderna nears FDA approval - what's next?

NASDAQ:MRNA   Moderna, Inc.
#MRNA got a positive report of FDA expert commission on its covid vaccine today.
Committee meeting is scheduled for Thursday and vaccine approval may be granted starting from Friday.

It's going to be the most expensive vaccine of all so the sale numbers won't be of a global scale.

Way up to $200 for the #MRNA stock is technically pathed through the correction at $140.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.